Three-pronged approach required for diplopia

Article

Diplopia is a common presenting complaint that has multiple underlying causes, both neurogenic and myogenic.

The first task is to determine whether the diplopia is monocular or binocular because the underlying causes and treatments are very different. Monocular diplopia usually occurs due to an uncorrected refractive error or corneal disorder that may be treated with refraction. "Other causes can be cataracts, scarring, or a dislocated lens, but monocular diplopia is rarely due to a nerve or muscle abnormality," he said.

Binocular diplopia is the more complex problem. The most common causes are cranial nerve palsy (cranial nerves III, IV, or VI), myasthenia gravis, thyroid-related ophthalmopathy, and orbital tumor.

"Approach the patient by taking a good history, measuring motility by a cover test in the seven positions of gaze, and evaluating associated findings, such as redness, ptosis, proptosis, pupillary abnormalities, and involvement of cranial nerves V and VII," Dr. Mitchell suggested. "Lab tests and imaging studies can help you home in on the right diagnosis."

Ophthalmoscopy is useful for noting any papilledema. Other clinical signs to look for include lid lag, lid retraction, and lid fatigue.

Diagnosing nerve palsies

Cover testing in seven positions of gaze is essential for diagnosing cranial nerve palsy. This test will reveal patterns of muscle weakness that directly correlate with cranial nerves III, IV and VI. Specifically:

Most cranial nerve palsies are ischemic in nature and self-resolve within 3 months. One caution: A third-nerve palsy that presents with pupil dilation and diplopia is a medical emergency, because this usually means an aneurysm at the posterior communicating artery. "These patients should undergo an MRI [magnetic resonance imaging] or MRA [magnetic resonance angiography] study that same day," Dr. Mitchell said.

Cancer or a compressive lesion should always be considered in non-resolving cranial nerve palsy or when two or more nerves are involved.

Myasthenia gravis

Ocular signs are the initial finding in some 75% of myasthenia gravis cases.1 Also, ocular findings are the only signs in more than half the cases of myasthenia gravis.1

"Consider myasthenia gravis in any patient presenting with diplopia, even in those with an isolated cranial nerve palsy pattern," Dr. Mitchell said.

A diurnal variation in diplopia-worsening during the day-is another common manifestation of myasthenia gravis. So, optometrists should question patients about patterns of diplopia.

Laboratory testing and electromyography can confirm the diagnosis of myasthenia gravis. Treatment for this neuromuscular disorder manages the autoimmune response to minimize symptoms, so optometrists should refer these patients to a neurologist.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD; and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
© 2025 MJH Life Sciences

All rights reserved.